|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000160180 |
Summary for TFF3 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000160180 | Gene symbol | TFF3 |
| Gene name | trefoil factor 3 | |
| HGNC | 11757 | |
| Entrez ID | 7033 | |
| Gene type | protein_coding | |
| Synonyms | TFF3|HITF|ITF | |
| UniProtAcc | Q07654 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for TFF3 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| TFF3 | 2.79e+02 | 1.12e+00 | 2.33e-01 | 4.78e+00 | 1.77e-06 | 6.70e-05 | HNSC |
| TFF3 | 1.05e+03 | -1.40e+00 | 2.18e-01 | -6.40e+00 | 1.54e-10 | 4.53e-08 | LUSC |
| TFF3 | 6.71e+01 | -1.05e+00 | 2.58e-01 | -4.05e+00 | 5.19e-05 | 5.16e-04 | KIRP |
| TFF3 | 1.44e+04 | 1.16e+00 | 3.20e-01 | 3.62e+00 | 2.98e-04 | 4.03e-02 | PAAD |
| TFF3 | 5.76e+02 | 2.90e+00 | 6.18e-01 | 4.69e+00 | 2.67e-06 | 1.41e-03 | CHOL |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| TFF3 | 6.98e+01 | -2.23e+00 | 4.08e-01 | -5.47e+00 | 4.47e-08 | 1.99e-07 | KIRP |
| TFF3 | 6.91e+02 | 2.36e+00 | 9.72e-01 | 2.43e+00 | 1.53e-02 | 3.57e-02 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| TFF3 | 8.77e+03 | 3.34e+00 | 6.76e-01 | 4.94e+00 | 7.72e-07 | 1.72e-05 | STAD |
| TFF3 | 4.98e+02 | 1.79e+00 | 4.75e-01 | 3.77e+00 | 1.63e-04 | 5.00e-04 | LIHC |
| TFF3 | 1.53e+04 | 2.56e+00 | 2.30e-01 | 1.11e+01 | 8.94e-29 | 4.36e-28 | BRCA |
Top |
Sex-biased somatic mutation for TFF3 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for TFF3 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg14283447 | chr21:42315302 | CGI:chr21:42305765-42306206 | promoter,exon,CDS,gene body | 4.31e-01 | 3.00e-01 | 2.24e+00 | 2.50e-02 | 3.81e-02 | 1.30e-01 |
| LIHC | cg20488657 | chr21:42316816 | CGI:chr21:42305765-42306206 | promoter | 6.26e-01 | 5.24e-01 | 3.87e+00 | 1.07e-04 | 7.41e-04 | 1.02e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg08198280 | chr21:42316955 | CGI:chr21:42305765-42306206 | promoter | 7.43e-01 | 8.46e-01 | -3.85e+00 | 1.19e-04 | 3.26e-04 | -1.03e-01 |
| LUAD | cg04806409 | chr21:42315395 | CGI:chr21:42305765-42306206 | promoter,exon,CDS,gene body | 4.91e-01 | 5.97e-01 | -4.76e+00 | 1.98e-06 | 1.15e-05 | -1.07e-01 |
| LUAD | cg24230696 | chr21:42316904 | CGI:chr21:42305765-42306206 | promoter | 8.18e-01 | 9.31e-01 | -4.21e+00 | 2.60e-05 | 9.17e-05 | -1.14e-01 |
| LUSC | cg18217706 | chr21:42314294 | CGI:chr21:42305765-42306206 | promoter,gene body | 7.47e-01 | 6.32e-01 | 3.33e+00 | 8.53e-04 | 2.34e-03 | 1.15e-01 |
| LUSC | cg14283447 | chr21:42315302 | CGI:chr21:42305765-42306206 | promoter,exon,CDS,gene body | 4.77e-01 | 6.27e-01 | -3.09e+00 | 1.97e-03 | 4.14e-03 | -1.50e-01 |
| COAD | cg19452276 | chr21:42316626 | CGI:chr21:42305765-42306206 | promoter | 4.42e-01 | 6.10e-01 | -3.78e+00 | 1.58e-04 | 5.04e-04 | -1.68e-01 |
| COAD | cg24230696 | chr21:42316904 | CGI:chr21:42305765-42306206 | promoter | 3.95e-01 | 5.10e-01 | -3.49e+00 | 4.85e-04 | 1.25e-03 | -1.15e-01 |
| BLCA | cg08198280 | chr21:42316955 | CGI:chr21:42305765-42306206 | promoter | 6.47e-01 | 7.84e-01 | -3.22e+00 | 1.26e-03 | 2.73e-03 | -1.37e-01 |
| BLCA | cg21970261 | chr21:42315734 | CGI:chr21:42305765-42306206 | promoter | 6.16e-01 | 8.09e-01 | -2.87e+00 | 4.10e-03 | 6.95e-03 | -1.92e-01 |
| BLCA | cg24230696 | chr21:42316904 | CGI:chr21:42305765-42306206 | promoter | 7.46e-01 | 9.08e-01 | -3.99e+00 | 6.56e-05 | 2.97e-04 | -1.62e-01 |
| LIHC | cg14283447 | chr21:42315302 | CGI:chr21:42305765-42306206 | promoter,exon,CDS,gene body | 4.93e-01 | 5.95e-01 | -3.38e+00 | 7.12e-04 | 1.17e-03 | -1.02e-01 |
| LIHC | cg19452276 | chr21:42316626 | CGI:chr21:42305765-42306206 | promoter | 6.17e-01 | 8.34e-01 | -2.47e+00 | 1.35e-02 | 1.58e-02 | -2.17e-01 |
| LIHC | cg20488657 | chr21:42316816 | CGI:chr21:42305765-42306206 | promoter | 5.24e-01 | 6.88e-01 | -2.84e+00 | 4.45e-03 | 5.95e-03 | -1.64e-01 |
| ESCA | cg18217706 | chr21:42314294 | CGI:chr21:42305765-42306206 | promoter,gene body | 6.44e-01 | 4.46e-01 | 2.27e+00 | 2.30e-02 | 4.14e-02 | 1.97e-01 |
| CHOL | cg20488657 | chr21:42316816 | CGI:chr21:42305765-42306206 | promoter | 8.24e-01 | 6.99e-01 | 2.80e+00 | 5.09e-03 | 1.63e-02 | 1.25e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg14283447 | chr21:42315302 | CGI:chr21:42305765-42306206 | promoter,exon,CDS,gene body | 4.31e-01 | 5.43e-01 | -7.31e+00 | 2.67e-13 | 8.55e-13 | -1.13e-01 |
| BRCA | cg21970261 | chr21:42315734 | CGI:chr21:42305765-42306206 | promoter | 5.01e-01 | 8.41e-01 | -1.05e+01 | 5.24e-26 | 4.91e-25 | -3.40e-01 |
| HNSC | cg14283447 | chr21:42315302 | CGI:chr21:42305765-42306206 | promoter,exon,CDS,gene body | 4.98e-01 | 3.77e-01 | 2.27e+00 | 2.30e-02 | 3.00e-02 | 1.22e-01 |
Top |
Exon skipping events with PSI in TCGA for TFF3 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for TFF3 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for TFF3 |
TFs related to TFF3.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| GBM | EBF1 | TFF3 | 2.28e+00 | 2.05e-03 | 3.93e+00 | 9.81e-01 | Female-biased |
| GBM | KLF8 | TFF3 | 1.56e+00 | 2.68e-04 | 3.87e+00 | 9.80e-01 | Female-biased |
| GBM | NHLH2 | TFF3 | 1.61e+00 | 2.74e-04 | 3.91e+00 | 9.82e-01 | Female-biased |
| GBM | ONECUT3 | TFF3 | 4.57e+00 | 9.82e-01 | 3.54e+00 | 1.18e-02 | Male-biased |
| GBM | TFAP2B | TFF3 | 1.44e+00 | 1.21e-04 | 3.95e+00 | 9.84e-01 | Female-biased |
| GBM | TFAP4 | TFF3 | 1.69e+00 | 3.00e-04 | 3.97e+00 | 9.84e-01 | Female-biased |
| GBM | TP73 | TFF3 | 2.25e+00 | 1.94e-03 | 3.92e+00 | 9.81e-01 | Female-biased |
| GBM | XPA | TFF3 | 1.73e+00 | 3.33e-04 | 3.98e+00 | 9.84e-01 | Female-biased |
| GBM | ZFX | TFF3 | 1.22e+00 | 6.31e-05 | 3.88e+00 | 9.81e-01 | Female-biased |
| GBM | ZNF16 | TFF3 | 1.50e+00 | 1.64e-04 | 3.93e+00 | 9.83e-01 | Female-biased |
| GBM | ZNF17 | TFF3 | 1.48e+00 | 1.02e-04 | 4.03e+00 | 9.86e-01 | Female-biased |
| GBM | ZNF28 | TFF3 | 6.49e-01 | 7.41e-07 | 4.06e+00 | 9.87e-01 | Female-biased |
| GBM | ZNF324B | TFF3 | 2.40e+00 | 2.56e-03 | 3.97e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF331 | TFF3 | 1.53e+00 | 8.52e-05 | 4.12e+00 | 9.89e-01 | Female-biased |
| GBM | ZNF37A | TFF3 | 1.05e+00 | 2.34e-05 | 3.91e+00 | 9.83e-01 | Female-biased |
| GBM | ZNF483 | TFF3 | 1.60e+00 | 3.16e-04 | 3.86e+00 | 9.80e-01 | Female-biased |
| GBM | ZNF524 | TFF3 | 2.58e+00 | 2.49e-03 | 4.16e+00 | 9.87e-01 | Female-biased |
| GBM | ZNF534 | TFF3 | 1.46e+00 | 1.56e-04 | 3.91e+00 | 9.82e-01 | Female-biased |
| GBM | ZNF573 | TFF3 | 1.84e+00 | 3.18e-04 | 4.10e+00 | 9.88e-01 | Female-biased |
| GBM | ZNF587 | TFF3 | 1.98e+00 | 6.59e-04 | 4.03e+00 | 9.86e-01 | Female-biased |
| GBM | ZNF594 | TFF3 | 1.80e+00 | 4.43e-04 | 3.97e+00 | 9.84e-01 | Female-biased |
| GBM | ZNF616 | TFF3 | 2.08e+00 | 6.05e-04 | 4.15e+00 | 9.89e-01 | Female-biased |
| GBM | ZNF708 | TFF3 | 2.33e+00 | 1.47e-03 | 4.10e+00 | 9.87e-01 | Female-biased |
| GBM | ZNF793 | TFF3 | 1.80e+00 | 2.16e-04 | 4.17e+00 | 9.90e-01 | Female-biased |
| GBM | ZNF816 | TFF3 | 1.04e+00 | 8.77e-06 | 4.06e+00 | 9.87e-01 | Female-biased |
| GBM | ZNF860 | TFF3 | 1.01e+00 | 1.28e-05 | 3.98e+00 | 9.85e-01 | Female-biased |
| GBM | ZNF891 | TFF3 | 1.23e+00 | 3.37e-05 | 4.03e+00 | 9.86e-01 | Female-biased |
| SARC | ZNF525 | TFF3 | 4.68e+00 | 9.81e-01 | 4.17e+00 | 1.36e-02 | Male-biased |
| SARC | ZNF534 | TFF3 | 4.31e+00 | 9.80e-01 | 3.76e+00 | 1.01e-02 | Male-biased |
| SARC | ZNF566 | TFF3 | 4.18e+00 | 9.84e-01 | 3.45e+00 | 3.42e-03 | Male-biased |
| SARC | ZNF611 | TFF3 | 4.43e+00 | 9.89e-01 | 3.65e+00 | 2.73e-03 | Male-biased |
TFF3 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for TFF3 |
RBPs related to ES in TFF3.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
TFF3 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs59540921 | chr21:41751626:G:A | - | 0.208767585762708 | 0.0450755032967621 | READ | Female-baised eQTL |
| rs73218414 | chr21:37429554:C:T | - | 0.0452139126361997 | 0.00205152515580293 | THCA | Female-baised eQTL |
| rs73216416 | chr21:37385385:G:A | - | 0.0438193955247772 | 0.00252588602548038 | THCA | Female-baised eQTL |
| rs11088390 | chr21:37387250:G:A | - | 0.0438193955247772 | 0.00252588602548038 | THCA | Female-baised eQTL |
| rs11700867 | chr21:37387936:T:G | - | 0.0438193955247772 | 0.00252588602548038 | THCA | Female-baised eQTL |
| rs73216422 | chr21:37388523:A:T | - | 0.0438193955247772 | 0.00252588602548038 | THCA | Female-baised eQTL |
| rs12482631 | chr21:37389178:C:T | - | 0.0438193955247772 | 0.00252588602548038 | THCA | Female-baised eQTL |
| rs11702026 | chr21:37389619:C:T | - | 0.0438193955247772 | 0.00252588602548038 | THCA | Female-baised eQTL |
| rs11702804 | chr21:37390726:A:G | - | 0.0438193955247772 | 0.00252588602548038 | THCA | Female-baised eQTL |
| rs56076624 | chr21:37391405:T:G | - | 0.0438193955247772 | 0.00252588602548038 | THCA | Female-baised eQTL |
| rs11701678 | chr21:37392737:C:T | - | 0.0438193955247772 | 0.00252588602548038 | THCA | Female-baised eQTL |
| rs11701900 | chr21:37380557:C:T | - | 0.0439562191641858 | 0.00279567464841848 | THCA | Female-baised eQTL |
| rs73203923 | chr21:37348669:T:G | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11700511 | chr21:37350960:A:T | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11700589 | chr21:37351269:C:T | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73203927 | chr21:37352104:T:C | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs56390513 | chr21:37408528:C:T | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs12481879 | chr21:37408826:C:T | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs56218358 | chr21:37409776:C:T | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216441 | chr21:37410216:A:G | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216443 | chr21:37411371:C:T | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216444 | chr21:37412683:G:A | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216446 | chr21:37413297:G:A | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216447 | chr21:37414750:C:T | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11701269 | chr21:37416344:T:C | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73218408 | chr21:37422259:T:C | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs55814414 | chr21:37424201:C:T | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73218413 | chr21:37427414:G:A | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11701483 | chr21:37427806:A:G | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11088394 | chr21:37429003:C:A | - | 0.0437580328318513 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73203931 | chr21:37356646:G:A | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11701585 | chr21:37357389:C:T | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11088388 | chr21:37359441:A:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11700559 | chr21:37359598:C:T | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs140756088 | chr21:37360606:T:C | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs138395243 | chr21:37361210:G:A | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73203932 | chr21:37362083:T:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11702873 | chr21:37363240:G:A | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11701064 | chr21:37363711:T:C | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73203934 | chr21:37364496:G:A | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73203935 | chr21:37364657:C:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73203936 | chr21:37365844:G:A | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs148485960 | chr21:37366156:G:A | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73203938 | chr21:37367978:C:T | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs55904712 | chr21:37369891:C:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11701386 | chr21:37371147:T:C | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73214094 | chr21:37371697:G:T | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73214095 | chr21:37372123:C:T | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11702765 | chr21:37372889:T:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11700732 | chr21:37373381:G:C | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11702136 | chr21:37375607:C:T | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs117017144 | chr21:37377161:C:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216404 | chr21:37377616:A:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216405 | chr21:37377766:C:T | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs12481981 | chr21:37378715:T:C | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216408 | chr21:37379761:T:C | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216409 | chr21:37380036:A:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11701862 | chr21:37380478:A:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216412 | chr21:37381786:C:A | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11700450 | chr21:37382301:T:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216414 | chr21:37384518:G:T | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11700779 | chr21:37395281:G:T | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs73216427 | chr21:37396464:A:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11702088 | chr21:37396975:G:A | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11702865 | chr21:37399539:A:G | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs12483564 | chr21:37402978:G:A | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11700804 | chr21:37403844:G:A | - | 0.043766342305578 | 0.00308225628410809 | THCA | Female-baised eQTL |
| rs11701469 | chr21:37427518:G:A | - | 0.0437312455115987 | 0.00313876569084154 | THCA | Female-baised eQTL |
| rs73218410 | chr21:37422286:C:T | - | 0.0437050469451353 | 0.00319950441126413 | THCA | Female-baised eQTL |
| rs55752073 | chr21:37369359:G:A | - | 0.0428157996461965 | 0.00432935033567794 | THCA | Female-baised eQTL |
| rs11088391 | chr21:37400366:G:A | - | 0.0423656536063527 | 0.00468046864450849 | THCA | Female-baised eQTL |
| rs17814633 | chr21:37397354:G:T | - | 0.0419041798130425 | 0.0059607173568159 | THCA | Female-baised eQTL |
| rs17814651 | chr21:37402263:G:A | - | 0.0419041798130425 | 0.0059607173568159 | THCA | Female-baised eQTL |
| rs11088393 | chr21:37415377:C:A | - | 0.041312761009053 | 0.00695531187391737 | THCA | Female-baised eQTL |
| rs11700902 | chr21:37403778:T:C | - | 0.0413212126188592 | 0.00695544847890331 | THCA | Female-baised eQTL |
| rs11701543 | chr21:37383581:C:T | - | 0.0412552496460661 | 0.00714591011345885 | THCA | Female-baised eQTL |
| rs2836716 | chr21:38864135:G:A | - | 0.0412748242640785 | 0.0430434579666132 | THCA | Female-baised eQTL |
| rs62217812 | chr21:38864645:A:G | - | 0.0412748242640785 | 0.0430434579666132 | THCA | Female-baised eQTL |
| rs35352430 | chr21:36791258:A:G | - | 0.214386257592181 | 0.0168881427020099 | KIRP | Female-baised eQTL |
| rs34820991 | chr21:36793001:C:T | - | 0.214386257592181 | 0.0168881427020099 | KIRP | Female-baised eQTL |
| rs9647072 | chr21:36794559:G:T | - | 0.214386257592181 | 0.0168881427020099 | KIRP | Female-baised eQTL |
| rs3787752 | chr21:36798134:G:A | - | 0.214386257592181 | 0.0168881427020099 | KIRP | Female-baised eQTL |
| rs3787754 | chr21:36799905:G:T | - | 0.226826838512861 | 0.0221939499258081 | KIRP | Female-baised eQTL |
| rs35524379 | chr21:36796098:G:A | - | 0.200919364320844 | 0.0337598348285259 | KIRP | Female-baised eQTL |
| rs35737292 | chr21:36796942:C:T | - | 0.200919364320844 | 0.0337598348285259 | KIRP | Female-baised eQTL |
| rs13050751 | chr21:36798658:A:G | - | 0.200919364320844 | 0.0337598348285259 | KIRP | Female-baised eQTL |
| rs7280160 | chr21:43708069:G:A | - | 0.229296115523527 | 0.0439004518135294 | KIRP | Female-baised eQTL |
| rs112430852 | chr21:45291209:G:A | - | 0.279991550803242 | 0.0495828537632022 | KIRP | Female-baised eQTL |
| rs1540015 | chr21:38656975:C:T | - | -0.104257737929897 | 0.0124817661965707 | LIHC | Female-baised eQTL |
| rs1015070 | chr21:38657437:T:G | - | -0.104257737929897 | 0.0124817661965707 | LIHC | Female-baised eQTL |
| rs1015069 | chr21:38657650:T:C | - | -0.104257737929897 | 0.0124817661965707 | LIHC | Female-baised eQTL |
| rs8134664 | chr21:38656497:T:C | - | -0.104342820209221 | 0.0129330652130891 | LIHC | Female-baised eQTL |
| rs460112 | chr21:38653301:C:T | - | -0.10430544825249 | 0.0137762300686227 | LIHC | Female-baised eQTL |
| rs1540016 | chr21:38657166:T:C | - | -0.102173772334408 | 0.0166267020345887 | LIHC | Female-baised eQTL |
| rs8132920 | chr21:38656019:C:T | - | -0.1033550160926 | 0.017769029148338 | LIHC | Female-baised eQTL |
| rs465004 | chr21:38649927:T:C | - | -0.0985488960254147 | 0.0321298016321506 | LIHC | Female-baised eQTL |
| rs463501 | chr21:38644361:T:G | - | -0.0977841930250441 | 0.032137376182022 | LIHC | Female-baised eQTL |
| rs465327 | chr21:38646547:G:A | - | -0.0977841930250441 | 0.032137376182022 | LIHC | Female-baised eQTL |
| rs404341 | chr21:44600338:A:G | - | -0.1436870665928 | 0.000203334981187921 | BLCA | Female-baised eQTL |
| rs452547 | chr21:44600407:G:A | - | -0.139147314627331 | 0.000360233809689031 | BLCA | Female-baised eQTL |
| rs464281 | chr21:44586005:C:G | - | 0.159796617020761 | 0.00121115140917266 | BLCA | Female-baised eQTL |
| rs1211103 | chr21:44600627:C:T | - | -0.124376806154969 | 0.00169831921504343 | BLCA | Female-baised eQTL |
| rs659638 | chr21:44601844:A:G | - | -0.121010225557209 | 0.0024289557690178 | BLCA | Female-baised eQTL |
| rs76934548 | chr21:44602732:C:G | - | -0.118484963278576 | 0.00278521633229322 | BLCA | Female-baised eQTL |
| rs116741704 | chr21:44602733:A:G | - | -0.118484963278576 | 0.00278521633229322 | BLCA | Female-baised eQTL |
| rs77769051 | chr21:44602736:C:T | - | -0.118484963278576 | 0.00278521633229322 | BLCA | Female-baised eQTL |
| rs76068886 | chr21:44602737:A:G | - | -0.118484963278576 | 0.00278521633229322 | BLCA | Female-baised eQTL |
| rs382935 | chr21:44603099:A:G | - | -0.112225036075797 | 0.0052944374155683 | BLCA | Female-baised eQTL |
| rs1211117 | chr21:44602757:A:G | - | -0.112339199093197 | 0.00541035922148179 | BLCA | Female-baised eQTL |
| rs1211118 | chr21:44602770:G:A | - | -0.112339199093197 | 0.00541035922148179 | BLCA | Female-baised eQTL |
| rs1211119 | chr21:44602855:T:C | - | -0.109450455812037 | 0.00721159614935264 | BLCA | Female-baised eQTL |
| rs71317703 | chr21:44602893:T:C | - | -0.109450455812037 | 0.00721159614935264 | BLCA | Female-baised eQTL |
| rs71317704 | chr21:44602898:A:G | - | -0.109450455812037 | 0.00721159614935264 | BLCA | Female-baised eQTL |
| rs1211122 | chr21:44602921:G:A | - | -0.109450455812037 | 0.00721159614935264 | BLCA | Female-baised eQTL |
| rs408958 | chr21:44603371:C:T | - | -0.109413537344128 | 0.00724516055472656 | BLCA | Female-baised eQTL |
| rs363877 | chr21:44601264:C:A | - | -0.109386420062575 | 0.00728118896253818 | BLCA | Female-baised eQTL |
| rs389167 | chr21:44601290:C:T | - | -0.109386420062575 | 0.00728118896253818 | BLCA | Female-baised eQTL |
| rs437149 | chr21:44601455:T:C | - | -0.109386420062575 | 0.00728118896253818 | BLCA | Female-baised eQTL |
| rs446817 | chr21:44601475:G:C | - | -0.109386420062575 | 0.00728118896253818 | BLCA | Female-baised eQTL |
| rs369720 | chr21:44601579:A:G | - | -0.109386420062575 | 0.00728118896253818 | BLCA | Female-baised eQTL |
| rs370092 | chr21:44601692:A:G | - | -0.109386420062575 | 0.00728118896253818 | BLCA | Female-baised eQTL |
| rs2276248 | chr21:44259375:T:C | - | 0.199797107278698 | 0.00889493549260232 | BLCA | Female-baised eQTL |
| rs2242916 | chr21:35188482:T:C | - | 0.137175163083651 | 0.0093041152799489 | BLCA | Female-baised eQTL |
| rs384645 | chr21:44602285:C:A | - | -0.106782753476758 | 0.00935058236210468 | BLCA | Female-baised eQTL |
| rs442226 | chr21:44602473:T:C | - | -0.106782753476758 | 0.00935058236210468 | BLCA | Female-baised eQTL |
| rs385033 | chr21:44602388:G:A | - | -0.106909069277726 | 0.00955639450198054 | BLCA | Female-baised eQTL |
| rs452002 | chr21:44602612:G:C | - | -0.104296226116704 | 0.0118830272713911 | BLCA | Female-baised eQTL |
| rs8133540 | chr21:34527578:A:C | - | 0.123236594750057 | 0.0151818378350523 | BLCA | Female-baised eQTL |
| rs460166 | chr21:44572572:G:A | - | 0.125131381717645 | 0.0154669049056792 | BLCA | Female-baised eQTL |
| rs392686 | chr21:44603751:T:G | - | -0.0998679192375679 | 0.0161568993840453 | BLCA | Female-baised eQTL |
| rs411914 | chr21:42979720:T:C | - | -0.125543749710647 | 0.0256205878237131 | BLCA | Female-baised eQTL |
| rs393280 | chr21:42979978:C:T | - | -0.125543749710647 | 0.0256205878237131 | BLCA | Female-baised eQTL |
| rs442845 | chr21:44596231:A:G | - | -0.118502413103824 | 0.027806028181888 | BLCA | Female-baised eQTL |
| rs442849 | chr21:44596238:A:G | - | -0.118502413103824 | 0.027806028181888 | BLCA | Female-baised eQTL |
| rs389936 | chr21:44596255:C:T | - | -0.118502413103824 | 0.027806028181888 | BLCA | Female-baised eQTL |
| rs1211088 | chr21:44596279:A:G | - | -0.118502413103824 | 0.027806028181888 | BLCA | Female-baised eQTL |
| rs7283084 | chr21:44682100:C:T | - | 0.0927190853751951 | 0.0346660939369847 | BLCA | Female-baised eQTL |
| rs414224 | chr21:43037328:A:C | - | -0.120813339417476 | 0.0361044511850407 | BLCA | Female-baised eQTL |
| rs4920035 | chr21:43037988:A:G | - | -0.120813339417476 | 0.0361044511850407 | BLCA | Female-baised eQTL |
| rs9981618 | chr21:44684401:G:T | - | 0.0895765679349687 | 0.0457718950221112 | BLCA | Female-baised eQTL |
| rs452847 | chr21:43024665:G:A | - | -0.115837248489731 | 0.0466898480283325 | BLCA | Female-baised eQTL |
| rs454555 | chr21:43024667:A:G | - | -0.115837248489731 | 0.0466898480283325 | BLCA | Female-baised eQTL |
| rs2839623 | chr21:43025677:A:T | - | -0.115883746601201 | 0.0470564915472802 | BLCA | Female-baised eQTL |
| rs234750 | chr21:42973944:C:G | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs1672115 | chr21:42975620:G:C | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs4920017 | chr21:42976165:G:A | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs4920019 | chr21:42976352:G:T | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs392619 | chr21:42976788:A:G | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs422052 | chr21:42977228:C:T | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs403415 | chr21:42977465:C:T | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs390431 | chr21:42978404:G:A | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs390473 | chr21:42978441:G:A | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs400262 | chr21:42980551:A:G | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs7281371 | chr21:42982848:T:C | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs11910337 | chr21:42983059:T:C | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs11910364 | chr21:42983099:T:G | - | -0.115711842301027 | 0.0478994530630298 | BLCA | Female-baised eQTL |
| rs9753937 | chr21:42970618:C:A | - | -0.115689395326718 | 0.0480038644472148 | BLCA | Female-baised eQTL |
| rs379361 | chr21:43042542:T:C | - | -0.115974765898344 | 0.049218618340137 | BLCA | Female-baised eQTL |
| rs400660 | chr21:43044602:T:C | - | -0.115996395265317 | 0.0498554712577904 | BLCA | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs71330629 | chr21:35977875:C:T | - | 0.0455859590961544 | 0.000369685599148863 | HNSC | Male-baised eQTL |
| rs2835192 | chr21:35974502:A:G | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs2835194 | chr21:35974759:C:T | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs34491110 | chr21:35975276:C:T | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs34544538 | chr21:35976088:A:G | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs35475771 | chr21:35978021:G:A | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs2835205 | chr21:35979008:C:T | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs56317271 | chr21:35979161:T:C | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs13048310 | chr21:35979504:C:T | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs13046307 | chr21:35980655:T:C | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs71330630 | chr21:35981383:T:C | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs79547672 | chr21:35985759:C:A | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs36028697 | chr21:35989534:A:C | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs2835215 | chr21:35990420:C:A | - | 0.0447439284137871 | 0.00048945962707808 | HNSC | Male-baised eQTL |
| rs2835193 | chr21:35974547:A:C | - | 0.0439135702079508 | 0.000657446118399474 | HNSC | Male-baised eQTL |
| rs2835216 | chr21:35991087:A:G | - | 0.0439135702079508 | 0.000657446118399474 | HNSC | Male-baised eQTL |
| rs2835190 | chr21:35972782:T:C | - | 0.0419154054725371 | 0.0010599161817565 | HNSC | Male-baised eQTL |
| rs13052673 | chr21:35973339:G:A | - | 0.0419154054725371 | 0.0010599161817565 | HNSC | Male-baised eQTL |
| rs13052382 | chr21:35973366:A:C | - | 0.0419154054725371 | 0.0010599161817565 | HNSC | Male-baised eQTL |
| rs915742 | chr21:35973859:A:G | - | 0.0426616788108868 | 0.00112513107423285 | HNSC | Male-baised eQTL |
| rs8133310 | chr21:35972349:T:C | - | 0.0390346562350391 | 0.00269517285360962 | HNSC | Male-baised eQTL |
| rs915741 | chr21:35973639:C:G | - | 0.0310770723068849 | 0.0281188070970246 | HNSC | Male-baised eQTL |
| rs10460711 | chr21:33591687:C:T | - | 0.0319390091661127 | 0.0398798413495065 | HNSC | Male-baised eQTL |
| rs139215564 | chr21:33546759:C:A | - | 0.0314801607864886 | 0.0451855341356802 | HNSC | Male-baised eQTL |
| rs12626839 | chr21:33556790:A:G | - | 0.0314865477122373 | 0.0456486475192698 | HNSC | Male-baised eQTL |
| rs182854 | chr21:44564865:C:G | - | -0.208016190675834 | 0.00111108050257317 | THCA | Male-baised eQTL |
| rs233255 | chr21:44561475:G:C | - | -0.20788103633655 | 0.00113302714325711 | THCA | Male-baised eQTL |
| rs233256 | chr21:44561801:G:C | - | -0.20788103633655 | 0.00113302714325711 | THCA | Male-baised eQTL |
| rs233253 | chr21:44559372:G:A | - | -0.20766318820037 | 0.0011695340622611 | THCA | Male-baised eQTL |
| rs233254 | chr21:44560594:C:T | - | -0.20766318820037 | 0.0011695340622611 | THCA | Male-baised eQTL |
| rs233257 | chr21:44561903:C:T | - | -0.186845431897786 | 0.0058907199714778 | THCA | Male-baised eQTL |
| rs233258 | chr21:44562462:A:C | - | -0.186484808873347 | 0.00606564953748076 | THCA | Male-baised eQTL |
| rs456780 | chr21:44568827:A:G | - | 0.186330620005768 | 0.00622130523644532 | THCA | Male-baised eQTL |
| rs233259 | chr21:44563040:G:T | - | -0.186302396147482 | 0.0062426550612469 | THCA | Male-baised eQTL |
| rs115728 | chr21:44563823:A:G | - | -0.186302396147482 | 0.0062426550612469 | THCA | Male-baised eQTL |
| rs170848 | chr21:44564406:G:C | - | -0.186081909828933 | 0.00646984882858653 | THCA | Male-baised eQTL |
| rs9984948 | chr21:41707156:C:A | - | 0.117773444096364 | 0.0136883758177701 | THCA | Male-baised eQTL |
| rs458563 | chr21:44571994:G:A | - | 0.168426817185172 | 0.0226572094830187 | THCA | Male-baised eQTL |
| rs461436 | chr21:44568676:C:T | - | 0.168207426951874 | 0.0233645818674886 | THCA | Male-baised eQTL |
| rs465079 | chr21:44569152:G:C | - | 0.168207426951874 | 0.0233645818674886 | THCA | Male-baised eQTL |
| rs457697 | chr21:44569308:C:T | - | 0.168207426951874 | 0.0233645818674886 | THCA | Male-baised eQTL |
| rs457698 | chr21:44569328:C:A | - | 0.168207426951874 | 0.0233645818674886 | THCA | Male-baised eQTL |
| rs191872249 | chr21:38972540:C:T | - | 0.161829864140377 | 0.00698927256069604 | SARC | Male-baised eQTL |
| rs192280242 | chr21:38972654:G:A | - | 0.161829864140377 | 0.00698927256069604 | SARC | Male-baised eQTL |
| rs2836799 | chr21:38975062:C:T | - | 0.161829864140377 | 0.00698927256069604 | SARC | Male-baised eQTL |
| rs2833900 | chr21:32561495:T:C | - | 0.0542316084783573 | 5.31703866358885e-05 | LUSC | Male-baised eQTL |
| rs9980120 | chr21:38959680:A:G | - | 0.0588474730678823 | 0.000498810274447546 | LUSC | Male-baised eQTL |
| rs2836794 | chr21:38971992:T:C | - | 0.0561661670822944 | 0.000559435417636022 | LUSC | Male-baised eQTL |
| rs58405653 | chr21:38972395:G:C | - | 0.0561661670822944 | 0.000559435417636022 | LUSC | Male-baised eQTL |
| rs60662852 | chr21:38972401:G:A | - | 0.0561661670822944 | 0.000559435417636022 | LUSC | Male-baised eQTL |
| rs58761542 | chr21:38972418:G:A | - | 0.0561661670822944 | 0.000559435417636022 | LUSC | Male-baised eQTL |
| rs57530862 | chr21:38972419:T:A | - | 0.0561661670822944 | 0.000559435417636022 | LUSC | Male-baised eQTL |
| rs8129295 | chr21:36390666:T:C | - | 0.0559465844528842 | 0.000567529040984124 | LUSC | Male-baised eQTL |
| rs8127277 | chr21:36394100:T:C | - | 0.0545858569710364 | 0.000829834681454281 | LUSC | Male-baised eQTL |
| rs2836793 | chr21:38970962:C:T | - | 0.0573029270186583 | 0.000830572498695482 | LUSC | Male-baised eQTL |
| rs9980681 | chr21:38974368:A:C | - | 0.0562127482454911 | 0.000910357942691538 | LUSC | Male-baised eQTL |
| rs9981682 | chr21:38974594:T:C | - | 0.0561841084459291 | 0.000924443018280336 | LUSC | Male-baised eQTL |
| rs9983903 | chr21:38975209:G:A | - | 0.0561841084459291 | 0.000924443018280336 | LUSC | Male-baised eQTL |
| rs78985292 | chr21:32512213:G:C | - | 0.0476428949937405 | 0.00093816543632347 | LUSC | Male-baised eQTL |
| rs75864658 | chr21:32491338:G:A | - | 0.0419685136660433 | 0.0126420563973958 | LUSC | Male-baised eQTL |
| rs79318608 | chr21:32491829:G:A | - | 0.041338254994745 | 0.0146875550392688 | LUSC | Male-baised eQTL |
| rs8131065 | chr21:36639378:C:T | - | 0.0339567280935465 | 0.021685967018805 | LUSC | Male-baised eQTL |
| rs1209954 | chr21:38809842:A:G | - | -0.0340006308800986 | 0.0301570076723694 | KIRC | Male-baised eQTL |
| rs162377 | chr21:43506121:C:T | - | 0.0547056135876326 | 0.046213937503416 | LUAD | Male-baised eQTL |
| rs11702745 | chr21:33137626:G:C | - | 0.0699192215944779 | 0.0157986992956111 | COAD | Male-baised eQTL |
| rs6518232 | chr21:45368384:A:C | - | 0.048932998611235 | 0.0369585537045557 | COAD | Male-baised eQTL |
| rs8129159 | chr21:45366298:A:G | - | 0.0490068088429152 | 0.0385959734720842 | COAD | Male-baised eQTL |
| rs8130914 | chr21:45367478:A:T | - | 0.0486798670758591 | 0.0407163740125748 | COAD | Male-baised eQTL |
| rs9941906 | chr21:45367726:T:C | - | 0.0486798670758591 | 0.0407163740125748 | COAD | Male-baised eQTL |
| rs6518235 | chr21:45369049:C:T | - | 0.0486798670758591 | 0.0407163740125748 | COAD | Male-baised eQTL |
| rs6518236 | chr21:45369050:C:G | - | 0.0486798670758591 | 0.0407163740125748 | COAD | Male-baised eQTL |
| rs73378923 | chr21:45376018:A:G | - | 0.04873231279226 | 0.0411700061650174 | COAD | Male-baised eQTL |
| rs3088146 | chr21:45372525:A:G | - | 0.0485636240732559 | 0.0424199343954282 | COAD | Male-baised eQTL |
| rs8129613 | chr21:45374854:G:A | - | 0.0481854855187671 | 0.0458036027314268 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg18217706 | chr21:42314294 | gene,promoter | -0.411754511457562 | 1.14189368360819e-21 | -0.8198991079193336 | 5.505673243198958e-25 | PAAD |
| cg19452276 | chr21:42316626 | promoter | -0.411754511457562 | 1.14189368360819e-21 | -0.8198991079193336 | 5.505673243198958e-25 | PAAD |
| cg14283447 | chr21:42315302 | gene,exon,CDS,promoter | -0.310511899268072 | 1.76195723924226e-13 | -0.7139313467279932 | 1.563540141809585e-16 | PAAD |
| cg20488657 | chr21:42316816 | promoter | -0.428103717140049 | 6.59013881428577e-13 | -0.7048097022672214 | 5.52794398805141e-16 | PAAD |
| cg24230696 | chr21:42316904 | promoter | -0.428103717140049 | 6.59013881428577e-13 | -0.7048097022672214 | 5.52794398805141e-16 | PAAD |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg14283447 | chr21:42315302 | gene,exon,CDS,promoter | -0.46969849656516 | 5.55840278569731e-07 | -0.6534574542140028 | 3.6831507112637493e-10 | KIRP |
| cg04806409 | chr21:42315395 | gene,exon,CDS,promoter | -0.325046182655171 | 2.56829901479366e-06 | -0.6292260014834795 | 2.489053797891419e-09 | KIRP |
| cg08198280 | chr21:42316955 | promoter | -0.488448713050012 | 8.16984675914818e-18 | -0.7619840452402784 | 6.47120515149886e-22 | BLCA |
| cg24230696 | chr21:42316904 | promoter | -0.402590990446753 | 6.73205393312694e-10 | -0.632638652525944 | 1.5900647964905653e-13 | BLCA |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of TFF3 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000160180 | TFF3 | C0019188 | Hepatitis, Animal | 1 | CTD_human |
| ENSG00000160180 | TFF3 | C0022658 | Kidney Diseases | 1 | CTD_human |
| ENSG00000160180 | TFF3 | C0022660 | Kidney Failure, Acute | 1 | CTD_human |
| ENSG00000160180 | TFF3 | C0333355 | Inflammatory disease of mucous membrane | 1 | CTD_human |
| ENSG00000160180 | TFF3 | C1565662 | Acute Kidney Insufficiency | 1 | CTD_human |
| ENSG00000160180 | TFF3 | C2609414 | Acute kidney injury | 1 | CTD_human |